Indian Pharma Exports: $10 Billion Opportunity in Off-Patent Drugs by 2029
June 27, 2024 19:09
Indian pharma industry set to benefit from USD 10 billion opportunity in off-patent drugs by 2029, with blockbuster drugs like Pembrolizumab and Eliquis going off-patent. Learn more about the...